ClinicalTrials.gg
CompletedNCT00046241Updated Jan 23, 2017

Prevention of Seasonal Affective Disorder

A Phase 3 interventional study of Extended-release bupropion hydrochloride in Seasonal Affective Disorder, sponsored by GlaxoSmithKline. Completed at 51 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-01-23.

Sponsored by GlaxoSmithKline · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 18 studies in Seasonal Affective Disorder with a site in United States — none open to participants now, none under way, none of them phase 3. Seasonal Affective Disorder · United States.

Enrollment
Largest of 15
300 · median 61
Started
2002
with 3 others
Phase 3
2 of 18
none open now
Registered
4th of 18
by date
Lead sponsor
3 of 18
GlaxoSmithKline

Among the 18 studies in Seasonal Affective Disorder with a site in United States, this one has the largest enrollment of the 15 interventional ones that give a count, is one of 4 that started in 2002, is one of 2 in phase 3, and was the 4th registered.

Seasonal Affective Disorder

31 studies on the registry are indexed under Seasonal Affective Disorder; 2 are open to participants now.

Browse Seasonal Affective Disorder studies →

Open to participants now

None of the 18 studies in Seasonal Affective Disorder with a site in United States is open now. The open studies under Seasonal Affective Disorder, anywhere →

Who these studies take

Of the 1 Seasonal Affective Disorder study recruiting now, 1 sets no upper age limit and none stop at 75 or younger; 1 takes children under 18; none take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 18 studies in Seasonal Affective Disorder with a site in United States as a file.
02

Study summary

This is a placebo controlled study evaluating the effectiveness of medication in preventing depressive episodes in subjects with a history of Seasonal Affective Disorder (SAD).

03

Conditions studied

  • Seasonal Affective Disorder

Keywords

  • seasonal depression winter blues winter depression
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

Exclusion criteria

Exclusion Criteria:

  • Patient has a current or past history of seizure disorder or brain injury.
  • Patient has a history or current diagnosis of anorexia nervosa or bulimia.
  • Patient has recurrent summer depression more frequently than winter depression.
  • Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
  • Patient has initiated psychotherapy within the last 3 months.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double
Enrollment
300 participants
06

What researchers measure

Primary outcomes

  1. Time between randomization and onset of a seasonal depressive episode. Proportion of depression-free subjects.

Secondary outcomes

  1. Change in HAMD-24 and -17 total score. Change in pain score.

07

Study locations

51 sites
  • GSK Clinical Trials Call Center
    Anchorage, Alaska 99508, United States
  • GSK Clinical Trials Call Center
    Hamden, Connecticut 06518, United States
  • GSK Clinical Trials Call Center
    Boise, Idaho 83702, United States
  • GSK Clinical Trials Call Center
    Chicago, Illinois 60637, United States
  • GSK Clinical Trials Call Center
    Edwardsville, Illinois 62025, United States
  • GSK Clinical Trials Call Center
    Oak Brook, Illinois 60523, United States
  • GSK Clinical Trials Call Center
    Oakbrook Terrace, Illinois 60181, United States
  • GSK Clinical Trials Call Center
    Lafayette, Indiana 47905, United States
  • GSK Clinical Trials Call Center
    Cedar Rapids, Iowa 52401, United States
  • GSK Clinical Trials Call Center
    Overland Park, Kansas 66211, United States
  • GSK Clinical Trials Call Center
    Baltimore, Maryland 21204, United States
  • GSK Clinical Trials Call Center
    Rockville, Maryland 20852, United States
  • GSK Clinical Trials Call Center
    Belmont, Massachusetts 02478, United States
  • GSK Clinical Trials Call Center
    Detroit, Michigan 48207, United States
  • GSK Clinical Trials Call Center
    Farmington Hills, Michigan 48334, United States
  • GSK Clinical Trials Call Center
    Minneapolis, Minnesota 55454, United States
  • GSK Clinical Trials Call Center
    St. Louis, Missouri 63108, United States
  • GSK Clinical Trials Call Center
    Omaha, Nebraska 68198, United States
  • GSK Clinical Trials Call Center
    Clementon, New Jersey 08021, United States
  • GSK Clinical Trials Call Center
    Kenilworth, New Jersey 07033, United States
  • GSK Clinical Trials Call Center
    Princeton, New Jersey 08540, United States
  • GSK Clinical Trials Call Center
    Albany, New York 12208, United States
  • GSK Clinical Trials Call Center
    New York, New York 10021, United States
  • GSK Clinical Trials Call Center
    New York, New York 10024, United States
  • GSK Clinical Trials Call Center
    New York, New York 10025, United States
  • GSK Clinical Trials Call Center
    Rochester, New York 14618, United States
  • GSK Clinical Trials Call Center
    Beachwood, Ohio 44122, United States
  • GSK Clinical Trials Call Center
    Cincinnati, Ohio 45267, United States
  • GSK Clinical Trials Call Center
    Dayton, Ohio 45415, United States
  • GSK Clinical Trials Call Center
    Marion, Ohio 43302, United States
  • GSK Clinical Trials Call Center
    Eugene, Oregon 97401, United States
  • GSK Clinical Trials Call Center
    Portland, Oregon 97210, United States
  • GSK Clinical Trials Call Center
    Portland, Oregon 97239, United States
  • GSK Clinical Trials Call Center
    Havertown, Pennsylvania 19083, United States
  • GSK Clinical Trials Call Center
    Jenkintown, Pennsylvania 19046, United States
  • GSK Clinical Trials Call Center
    Philadelphia, Pennsylvania 19131, United States
  • GSK Clinical Trials Call Center
    East Providence, Rhode Island 02915, United States
  • GSK Clinical Trials Call Center
    Woodstock, Vermont 05091, United States
  • GSK Clinical Trials Call Center
    Falls Church, Virginia 22041, United States
  • GSK Clinical Trials Call Center
    Bellevue, Washington 98004, United States
  • GSK Clinical Trials Call Center
    Seattle, Washington 98105, United States
  • GSK Clinical Trials Call Center
    Spokane, Washington 99204, United States
  • GSK Clinical Trials Call Center
    Brown Deer, Wisconsin 53223, United States
  • GSK Clinical Trials Call Center
    Calgary, Alberta T2X 2A8, Canada
  • GSK Clinical Trials Call Center
    Edmonton, Alberta T6L 5X8, Canada
  • GSK Clinical Trials Call Center
    Kelowna, British Columbia V1Y 2A3, Canada
  • GSK Clinical Trials Call Center
    Winnipeg, Manitoba R3E 3N4, Canada
  • GSK Clinical Trials Call Center
    Toronto, Ontario M4T 1K2, Canada
  • GSK Clinical Trials Call Center
    Toronto, Ontario M9W 4L6, Canada
  • GSK Clinical Trials Call Center
    Montreal, Quebec H2L 1H9, Canada
  • GSK Clinical Trials Call Center
    Sherbrooke, Quebec J1G 1W4, Canada
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2002 to primary completion in Jun 2003, 9 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 24, 2002
First posted
Sep 25, 2002
StartActual
Sep 2002
Primary completionActual
Jun 2003
CompletionActual
Jun 2003
Last update
Jan 23, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00046241
Lead sponsor
GlaxoSmithKline
First posted
Sep 25, 2002
Start date
Sep 2002
Primary completion
Jun 2003
Completion
Jun 2003
Last update
Jan 23, 2017

Study contacts

GSK Clinical Trial, MD
study director · GlaxoSmithKline
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Bupropion

Start the discussion